Haitian Creole Haitian Creole
en Englishaf Afrikaanssq Albanianar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbg Bulgarianca Catalanzh-CN Chinese (Simplified)zh-TW Chinese (Traditional)hr Croatiancs Czechda Danishnl Dutchet Estoniantl Filipinofi Finnishfr Frenchgl Galicianka Georgiande Germanel Greekht Haitian Creoleiw Hebrewhi Hindihu Hungarianis Icelandicid Indonesianga Irishit Italianja Japaneseko Koreanlv Latvianlt Lithuanianmk Macedonianms Malaymt Malteseno Norwegianfa Persianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsw Swahilisv Swedishth Thaitr Turkishuk Ukrainianur Urduvi Vietnamesecy Welshyi Yiddish

Podcasts

Pati 2: Pre-egziste Iminite kont serotipar AAV ak sa sa vle di pou Hemophilia jèn terapi nan klinik tras

Prezante pa Steven W. Pipe, MD ak Nigel Key, MB, ChB. FRCP

Adeno-Associated Viris (AAV) Medyatè Transfè Gene: Poukisa sa a se estrateji nan predominan pou Terapi jèn emofil?

Prezante pa Steven W. Pipe, MD ak Nigel Key, MB, ChB. FRCP

Alontèm Siveyans Apre Terapi jèn emofil

Prezante pa Steven W. Pipe, MD ak Nigel Key, MB, ChB. FRCP

Pwen esansyèl ki soti nan NHF 15th Atelye sou Novel teknoloji ak Transfè Gene pou Emofili

Prezante pa David Lillicrap, MD ak Glenn F. Peirce, MD, PhD

Gwoup Travay Terapi Gene EAHAD

Prezante pa Wolfgang Miesbach, MD

Istwa EAHAD ak Kongrè kap vini an

Prezante pa Aislin Ryan, CEO nan EAHAD

ISTH Terapi jèn pou Inisyativ emofili ak wòl nan EAHAD

Prezante pa Flora Peyvandi, MD, PhD

Back, pou ouvèti
Imaj

Please enable the javascript to submit this form

Enfòmasyon Sou

Sipòte pa sibvansyon edikasyon bay Bayer, BioMarin, CSL Behring, Freeline Therapeutics Limited, Pfizer Inc., Spark Therapeutics, ak uniQure, Inc.

Esansyèl SSL